P13.02 Conventional MRI radiomics in the diagnosis of early- and pseudo-progression

BACKGROUND: After radiochemotherapy, 20% to 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic performance and survival predictive ability of radiomics in patients with suspected EP o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Bani Sadr, A, Eker, O F, Berner, L, Ameli, R, Hermier, M, Barritault, M, Meyronet, D, Guyotat, J, Jouanneau, E, Honnorat, J, Ducray, F, Berthezène, Y
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796042/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.223
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars